Contact details

Type of addressPostal address
Postal codeYO10 5DD
CountryUnited Kingdom
Address lines
  • Centre for Health Economics
    University of York
    Heslington
    York
    YO10 5DD

Phone: (01904) 321488

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

Mr. Paul Revill

Senior Research Fellow

  1. 2019
  2. Economic Analysis for Health Benefits Package Design

    Love-Koh, J., Walker, S. M., Kataika, E., Sibandze, S., Arnold, M., Ochalek, J. M., Griffin, S., Revill, P. & Sculpher, M. J., 11 Jun 2019, York, UK: Centre for Health Economics, University of York, 24 p. (CHE Research Paper; no. 165).

    Research output: Working paperDiscussion paper

  3. Targeting and Vaccine Durability Are Key for Population-level Impact and Cost-Effectiveness of a Pox-Protein HIV Vaccine Regimen in South Africa

    Selinger, C., Bershteyn, A., Dimitrov, DT., Adamson, BJS., Revill, P., Hallett, T., Phillips, AN., Bekker, LG., Rees, H. & Gray, G., 10 Apr 2019

    Article in Vaccine

  4. The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa. A health economic and modelling analysis

    Cambiano, V., Johnson, C., Hatzold, K., Terris-Prestholt, F., Haheswaran, H., Thirumurthy, H., Figueroa, C., Cowan, F., Sibanda, E., Ncube, G., Revill, P., Corbett, L., Baggaley, R. & Phillips, A., 25 Mar 2019

    Article in Journal of the international aids society

  5. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study

    Bórquez, A., Guanira, J. V., Revill, P., Caballero, P., Silva-Santisteban, A., Kelly, S., Salazar, X., Bracamonte, P., Minaya, P., Hallett, T. B. & Cáceres, C. F., 22 Jan 2019

    Article in The Lancet Public Health

  6. Incorporating concerns for equity into health resource allocation: A guide for practitioners

    Love-Koh, J., Griffin, S., Kataika, E., Revill, P., Sibandze, S. & Walker, S. M., 21 Jan 2019, York, 20 p. (CHE Research Paper).

    Research output: Working paperDiscussion paper

  7. 2018
  8. Recommendations for the development of a health sector resource allocation formula in Malawi

    McGuire, F., Revill, P., Twea, P., Mohan, S., Manthalu, G. & Smith, P. C., Dec 2018, York, UK: Centre for Health Economics, University of York, 40 p. (CHE Research Paper; no. 159).

    Research output: Working paperDiscussion paper

  9. Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study

    Phillips, A., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D., Wensing, A., Lundgren, J., De Luca, A., Pillay, D., Mellors, J., Cambiano, V., Bansi-Matharu, L., Nakagawa, F., Kalua, T., Jahn, A., Apollo, T., Mugurungi, O., Clayden, P., Gupta, R., Barnabas, R. & 4 othersRevill, P., Cohn, J., Bertagnolio, S. & Calmy, A., 29 Nov 2018

    Article in The Lancet HIV

  10. Fresh money for health? The (false?) promise of “innovative financing” for health in Malawi

    Chansa, C., Mwase, T., Matsebula, T., Kandoole, P., Revill, P., Makumba, J-B. & Lindelow, M., 29 Oct 2018

    Article in Health Systems & Reform

  11. Economic analysis of vaccination programs

    Mauskopf, J., Standaert, B., Connolly, M. P., Culyer, A. J., Garrison, L. P., Hutubessy, R., Jit, M., Pitman, R., Revill, P. & Severens, J. L., 1 Oct 2018

    Article in Value in Health

  12. Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study

    Dodd, P. J., Yuen, C. M., Becerra, M. C., Revill, P., Jenkins, H. E. & Seddon, J. A., 25 Sep 2018

    Article in Lancet Global Health

  13. Setting research priorities in Global Health: appraising the value of evidence generation activities to support decision-making in health care

    Woods, B. S., Rothery, C., Revill, P., Hallett, T. & Phillips, A., Jun 2018, York: Centre for Health Economics, University of York, p. 1-54, 55 p. (CHE Research Paper; no. 155).

    Research output: Working paperDiscussion paper

  14. Supporting the development of a health benefits package in Malawi

    Ochalek, J., Revill, P., Manthalu, G., McGuire, F., Nkhoma, D., Rollinger, A., Sculpher, M. & Claxton, K., 9 Apr 2018

    Article in BMJ Global health

  15. Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries

    Tierrablanca, L. E., Ochalek, J. M., Ford, D., Babiker, A. G., Gibb, D. M., Butler, K., Turkova, A., Griffin, S. & Revill, P., 1 Feb 2018

    Article in Medicine

  16. Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda

    Abongomera, G., Chiwaula, L., Revill, P., Mabugu, T., Tumwesige, E., Nkhata, M. J., Cataldo, F., van Oosterhout, J., Colebunders, R., Chan, A. K., Kityo, C., Gilks, C. F., Hakim, J., Seeley, J., Gibb, D. M. & Ford, D., 10 Jan 2018

    Article in International Health

  17. 2017
  18. Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

    Phillips, A. N., Cambiano, V., Nakagawa, F., Revill, P., Jordan, M. R., Hallett, T. B., Doherty, M., De Luca, A., Lundgren, J. D., Mhangara, M., Apollo, T., Mellors, J., Nichols, B., Parikh, U., Pillay, D., Rinke de Wit, T., Sigaloff, K., Havlir, D., Kuritzkes, D. R., Pozniak, A. & 6 othersvan de Vijver, D., Vitoria, M., Wainberg, M. A., Raizes, E., Bertagnolio, S. & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa, 22 Nov 2017

    Article in Lancet HIV

  19. Confronting Tight Fiscal, Human Resource, and Evidence Constraints, Malawi Revises Its Benefits Package

    Manthalu, G., Nkhoma, D., Ochalek, J. M., Phillips, A. & Revill, P., 10 Oct 2017, What's In, What's Out: Designing Benefits for Universal Health Coverage. Glassman, A., Giedion, U. & Smith, P. C. (eds.). Washington D.C.: Center for Global Development

    Research output: Chapter in Book/Report/Conference proceedingChapter

  20. How Much Health for the Money? Using Cost-Effectiveness Analysis to Support Benefits Plan Decisions

    Sculpher, M. J., Revill, P., Ochalek, J. M. & Claxton, K. P., 10 Oct 2017, What’s In, What’s Out: Designing Benefits for Universal Health Coverage. Glassman, A., Giedion, U. & Smith, P. C. (eds.). Washington D.C.: Center for Global Development

    Research output: Chapter in Book/Report/Conference proceedingChapter

  21. Public financial management and health service delivery: A literature review

    Goryakin, Y., Revill, P., Mirelman, A., Sweeney, R., Ochalek, J. M. & Suhrcke, M. E., Apr 2017, London, 43 p. (Overseas Development Institute Report).

    Research output: Working paperDiscussion paper

  22. Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys

    Abongomera, G., Kiwuwa-Muyingo, S., Revill, P., Chiwaula, L., Mabugu, T., Phillips, A. N., Katabira, E., Chan, A. K., Gilks, C., Musiime, V., Hakim, J., Kityo, C., Colebunders, R., Gibb, D. M., Seeley, J., Ford, D. & Lablite Project Team, 10 Mar 2017

    Article in International Health

  23. Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa

    Phillips, A. N., Stover, J., Cambiano, V., Nakagawa, F., Jordan, M. R., Pillay, D., Doherty, M., Revill, P. & Bertagnolio, S., 17 Feb 2017

    Article in The Journal of Infectious Diseases

  24. 2016
  25. Cost effectiveness of potential ART adherence monitoring interventions in sub-saharan Africa

    Phillips, A. N., Cambiano, V., Nakagawa, F., Bansi-Matharu, L., Sow, P. S., Ehrenkranz, P., Ford, D., Mugurungi, O., Apollo, T., Murungu, J., Bangsberg, D. R. & Revill, P., 15 Dec 2016

    Article in PLoS ONE

  26. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

    Wilkinson, T., Sculpher, M. J., Claxton, K., Revill, P., Briggs, A., Cairns, J. A., Teerawattananon, Y., Asfaw, E., Lopert, R., Culyer, A. J. & Walker, D. G., Dec 2016

    Article in Value in Health

  27. Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study

    Nkhata, M. J., Muzambi, M., Ford, D., Chan, A. K., Abongomera, G., Namata, H., Mambule, I., South, A., Revill, P., Grundy, C., Mabugu, T., Chiwaula, L., Hakim, J., Kityo, C., Reid, A., Katabira, E., Sodhi, S., Gilks, C. F., Gibb, D. M., Seeley, J. & 2 othersCataldo, F. & Lablite team, 16 Nov 2016

    Article in BMC Health Services Research

  28. Measuring and valuing informal care for economic evaluations of HIV/AIDS interventions: methods and application in Malawi

    Chiwaula, L., Revill, P., Ford, D., Nkhata, M. J., Mabugu, T., Hakim, J., Kityo, C., Chan, A., Cataldo, F., Gibb, D. M. & van den Berg, B., 16 Sep 2016

    Article in Value in Health Regional Issues

  29. Supporting the development of an essential health package: principles and initial assessment for Malawi

    Ochalek, J. M., Claxton, K. P., Revill, P., Sculpher, M. J. & Rollinger, A., Sep 2016, York, UK: Centre for Health Economics, University of York, p. 1-90, 90 p. (CHE Research Paper; no. 136).

    Research output: Working paperDiscussion paper

  30. Point-of-care viral load testing for sub-Saharan Africa: informing a target product profile

    Phillips, A., Cambiano, V., Nakagawa, F., Ford, D., Apollo, T., Murungu, J., Rousseau, C., Garnett, G., Ehrenkranz, P., Bansi-Matharu, L., Vojnov, L., Katz, Z., Peeling, R. & Revill, P., 29 Jul 2016

    Article in Open Forum Infectious Diseases

  31. Identifying key drivers of the impact of an HIV cure intervention in sub-Saharan Africa

    Phillips, A., Cambiano, V., Revill, P., Nakagawa, F., Lundgren, J., Bansi-Matharu, L., Mabugu, T., Sculpher, M., Garnett, G., Staprans, S., Becker, S., Murungu, J., Lewin, S. R., Deeks, S. G. & Hallett, T., 30 Mar 2016

    Article in The Journal of Infectious Diseases

  32. The cost-effectiveness of interventions to prevent HIV acquisition

    Garnett, G., Krishnaratne, S., Harris, K., Hallett, T., Santos, M., Endstone, J., Hensen, B., Dallabetta, G., Revill, P., Gregson, S. & Hargreaves, J., 2016, (Accepted/In press) Disease Control Priorities 3: HIV/AIDS and Other Sexually Transmitted Infections.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  33. 2015
  34. Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda

    Abongomera, G., Kiwuwa-Muyingo, S., Revill, P., Chiwaula, L., Mabugu, T., Phillips, A., Katabira, E., Musiime, V., Gilks, C., Chan, A., Hakim, J., Colebunders, R., Kityo, C., Gibb, D. M., Seeley, J., Ford, D. & Lablite Project Team, 11 Dec 2015

    Article in BMC Health Services Research

  35. Sustainable HIV treatment in Africa through viral-load-informed differentiated care

    Phillips, A., Shroufi, A., Vojnov, L., Cohn, J., Roberts, T., Ellman, T., Bonner, K., Rousseau, C., Garnett, G., Cambiano, V., Nakagawa, F., Ford, D., Bansi-Matharu, L., Miners, A., Lundgren, J. D., Eaton, J. W., Parkes-Ratanshi, R., Katz, Z., Maman, D., Ford, N. & 30 othersVitoria, M., Doherty, M., Dowdy, D., Nichols, B., Murtagh, M., Wareham, M., Palamountain, K. M., Chakanyuka Musanhu, C., Stevens, W., Katzenstein, D., Ciaranello, A., Barnabas, R., Braithwaite, R. S., Bendavid, E., Nathoo, K. J., van de Vijver, D., Wilson, D. P., Holmes, C., Bershteyn, A., Walker, S., Raizes, E., Jani, I., Nelson, L. J., Peeling, R., Terris-Prestholt, F., Murungu, J., Mutasa-Apollo, T., Hallett, T. B., Revill, P. & Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa, 2 Dec 2015

    Article in Nature

  36. Cost-effectiveness thresholds: guiding health care spending for population health improvement

    Revill, P., Ochalek, J. M., Lomas, J. R. S., Nakamura, R., Woods, B. S., Rollinger, A., Suhrcke, M. E., Sculpher, M. J. & Claxton, K. P., Nov 2015, The International Decision Support Initiative.

    Research output: Book/ReportCommissioned report

  37. Country-level cost-effectiveness thresholds: initial estimates and the need for further research.

    Woods, B., Revill, P., Sculpher, M. & Claxton, K. P., Mar 2015, York, UK: Centre for Health Economics, University of York, p. 1-24, 24 p. (CHE Research Paper; no. 109).

    Research output: Working paperDiscussion paper

  38. Opportunities for improving the efficiency of paediatric HIV treatment programmes: lessons from the ARROW trial

    Revill, P. A., Walker, S., Mabugu, T., Nathoo, K. J., Mugyenyi, P., Kekitinwa, A., Munderi, P., Bwakura-Dangarembizi, M., Musiime, V., Bakeera-Kitaka, S., Nahirya-Ntege, P., Walker, A. S., Sculpher, M. J. & Gibb, D. M., 14 Jan 2015

    Article in AIDS (London, England)

  39. Improving survival of retinoblastoma in Uganda

    Waddell, K. M., Kagame, K., Ndamira, A., Twinamasiko, A., Picton, S. V., Simmons, I. G., Revill, P., Johnston, W. T. & Newton, R., 12 Jan 2015

    Article in British Journal of Ophthalmology

  40. Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries

    Cambiano, V., Ford, D., Mabugu, T., Napierala Mavedzenge, S., Miners, A., Mugurungi, O., Nakagawa, F., Revill, P. & Phillips, A., 2015

    Article in The Journal of Infectious Diseases

  41. Economic Evaluation of Healthcare Programs and Interventions: Applications to Low- and Middle-Income Countries

    Revill, P., Woods, B. & Sculpher, M., 2015, World Scientific Handbook of Global Health Economics and Public Policy. Scheffler, R. M. (ed.). World Scientific Publishing, Vol. 1.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  42. The Costs and Benefits of Alternatives Approaches to Monitoring Patients on Antiretroviral Therapy: Modelling and Economic Analysis

    Revill, P., Phillips, A. & Hallett, T., 2015, HIV Modelling Consortium report for the World Health Organization HIV Treatment Guidelines Development Committee. 20 p.

    Research output: Book/ReportCommissioned report

  43. 2014
  44. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis

    Phillips, A., Cambiano, V., Miners, A., Revill, P., Pillay, D., Lundgren, J., Bennett, D., Raizes, E., Nakagawa, F., De Luca, A., Vitoria, M., Barcarolo, J., Perriens, J., Jordan, M. & Bertagnolio, S., Nov 2014

    Article in The Lancet HIV

  45. Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings

    Phillips, A., Cambiano, V., Nakagawa, F., Magubu, T., Miners, A., Ford, D., Pillay, D., De Luca, A., Lundgren, J. & Revill, P., 7 Oct 2014

    Article in PLoS ONE

Previous 1 2 Next